Clinical trial
Prognosis of Anti-GBM Antibody Disease Through an International Cohort
NCT07018024 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognosis of Anti-GBM Antibody Disease Through an International Cohort
- Lead sponsor
- Region Skane
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2024
- Completion date
- December 31, 2028
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.